TY - JOUR
T1 - Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial Risk
AU - KConFab Investigators
AU - Kehm, Rebecca D.
AU - MacInnis, Robert J.
AU - John, Esther M.
AU - Liao, Yuyan
AU - Kurian, Allison W.
AU - Genkinger, Jeanine M.
AU - Knight, Julia A.
AU - Colonna, Sarah V.
AU - Chung, Wendy K.
AU - Milne, Roger
AU - Zeinomar, Nur
AU - Dite, Gillian S.
AU - Southey, Melissa C.
AU - Giles, Graham G.
AU - McLachlan, Sue Anne
AU - Whitaker, Kristen D.
AU - Friedlander, Michael L.
AU - Weideman, Prue C.
AU - Glendon, Gord
AU - Nesci, Stephanie
AU - Phillips, Kelly Anne
AU - Andrulis, Irene L.
AU - Buys, Saundra S.
AU - Daly, Mary B.
AU - Hopper, John L.
AU - Terry, Mary Beth
N1 - Publisher Copyright:
© The Author(s) 2021. Published by Oxford University Press.
PY - 2021/12/1
Y1 - 2021/12/1
N2 - Background: Recreational physical activity (RPA) is associated with improved survival after breast cancer (BC) in average-risk women, but evidence is limited for women who are at increased familial risk because of a BC family history or BRCA1 and BRCA2 pathogenic variants (BRCA1/2 PVs). Methods: We estimated associations of RPA (self-reported average hours per week within 3 years of BC diagnosis) with all-cause mortality and second BC events (recurrence or new primary) after first invasive BC in women in the Prospective Family Study Cohort (n = 4610, diagnosed 1993-2011, aged 22-79 years at diagnosis). We fitted Cox proportional hazards regression models adjusted for age at diagnosis, demographics, and lifestyle factors. We tested for multiplicative interactions (Wald test statistic for cross-product terms) and additive interactions (relative excess risk due to interaction) by age at diagnosis, body mass index, estrogen receptor status, stage at diagnosis, BRCA1/2 PVs, and familial risk score estimated from multigenerational pedigree data. Statistical tests were 2-sided. Results: We observed 1212 deaths and 473 second BC events over a median follow-up from study enrollment of 11.0 and 10.5 years, respectively. After adjusting for covariates, RPA (any vs none) was associated with lower all-cause mortality of 16.1% (95% confidence interval [CI] = 2.4% to 27.9%) overall, 11.8% (95% CI = -3.6% to 24.9%) in women without BRCA1/2 PVs, and 47.5% (95% CI = 17.4% to 66.6%) in women with BRCA1/2 PVs (RPA*BRCA1/2 multiplicative interaction P = .005; relative excess risk due to interaction = 0.87, 95% CI = 0.01 to 1.74). RPA was not associated with risk of second BC events. Conclusion: Findings support that RPA is associated with lower all-cause mortality in women with BC, particularly in women with BRCA1/2 PVs.
AB - Background: Recreational physical activity (RPA) is associated with improved survival after breast cancer (BC) in average-risk women, but evidence is limited for women who are at increased familial risk because of a BC family history or BRCA1 and BRCA2 pathogenic variants (BRCA1/2 PVs). Methods: We estimated associations of RPA (self-reported average hours per week within 3 years of BC diagnosis) with all-cause mortality and second BC events (recurrence or new primary) after first invasive BC in women in the Prospective Family Study Cohort (n = 4610, diagnosed 1993-2011, aged 22-79 years at diagnosis). We fitted Cox proportional hazards regression models adjusted for age at diagnosis, demographics, and lifestyle factors. We tested for multiplicative interactions (Wald test statistic for cross-product terms) and additive interactions (relative excess risk due to interaction) by age at diagnosis, body mass index, estrogen receptor status, stage at diagnosis, BRCA1/2 PVs, and familial risk score estimated from multigenerational pedigree data. Statistical tests were 2-sided. Results: We observed 1212 deaths and 473 second BC events over a median follow-up from study enrollment of 11.0 and 10.5 years, respectively. After adjusting for covariates, RPA (any vs none) was associated with lower all-cause mortality of 16.1% (95% confidence interval [CI] = 2.4% to 27.9%) overall, 11.8% (95% CI = -3.6% to 24.9%) in women without BRCA1/2 PVs, and 47.5% (95% CI = 17.4% to 66.6%) in women with BRCA1/2 PVs (RPA*BRCA1/2 multiplicative interaction P = .005; relative excess risk due to interaction = 0.87, 95% CI = 0.01 to 1.74). RPA was not associated with risk of second BC events. Conclusion: Findings support that RPA is associated with lower all-cause mortality in women with BC, particularly in women with BRCA1/2 PVs.
UR - http://www.scopus.com/inward/record.url?scp=85137830423&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85137830423&partnerID=8YFLogxK
U2 - 10.1093/jncics/pkab090
DO - 10.1093/jncics/pkab090
M3 - Article
C2 - 34950851
AN - SCOPUS:85137830423
SN - 2515-5091
VL - 5
JO - JNCI Cancer Spectrum
JF - JNCI Cancer Spectrum
IS - 6
M1 - pkab090
ER -